Migrevention is an Estonian health technology company and Estonia’s first software based medical device manufacturer (since 2022). Migrevention is a fully digital headache clinic and we offer digital solutions for patients, specialists and clinics to monitor, diagnose and treat migraine and other primary headaches. We enable to rethink the patient-specialist relationship by creating innovative solutions in personal medicine. Migrevention’s mission is raising awareness and providing more accessible treatment to over 1.4B migraine patients in the world through a digital therapeutic. At the moment, only 1-4% of migraine patients get evidence-based treatment, and the vast majority stays undiagnosed and untreated. Without sufficient treatment, the medical costs add up to 155 billion € per year only in the EU; and risks for migraine chronification, secondary health problems and medication overuse headache rise drastically.